PL1753512T3 - Tetrahydropirydotiofeny - Google Patents
TetrahydropirydotiofenyInfo
- Publication number
- PL1753512T3 PL1753512T3 PL05749649T PL05749649T PL1753512T3 PL 1753512 T3 PL1753512 T3 PL 1753512T3 PL 05749649 T PL05749649 T PL 05749649T PL 05749649 T PL05749649 T PL 05749649T PL 1753512 T3 PL1753512 T3 PL 1753512T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrahydropyridothiophenes
- compounds
- proliferative
- description
- meanings indicated
- Prior art date
Links
- WJFYLCXWEXZNHU-UHFFFAOYSA-N 2,3,3a,4-tetrahydrothieno[3,2-b]pyridine Chemical class N1C=CC=C2SCCC21 WJFYLCXWEXZNHU-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000006909 anti-apoptosis Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04102413 | 2004-05-28 | ||
| EP04104193 | 2004-09-01 | ||
| EP05749649A EP1753512B1 (en) | 2004-05-28 | 2005-05-25 | Tetrahydropyridothiophenes |
| PCT/EP2005/052384 WO2005118071A2 (en) | 2004-05-28 | 2005-05-25 | Tetrahydropyridothiophenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1753512T3 true PL1753512T3 (pl) | 2009-03-31 |
Family
ID=35045196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05749649T PL1753512T3 (pl) | 2004-05-28 | 2005-05-25 | Tetrahydropirydotiofeny |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7723523B2 (pl) |
| EP (1) | EP1753512B1 (pl) |
| JP (1) | JP4881297B2 (pl) |
| KR (1) | KR20070037578A (pl) |
| CN (1) | CN1988934B (pl) |
| AT (1) | ATE400319T1 (pl) |
| AU (1) | AU2005249718B2 (pl) |
| BR (1) | BRPI0511461A (pl) |
| CA (1) | CA2567648A1 (pl) |
| CY (1) | CY1108399T1 (pl) |
| DE (1) | DE602005008050D1 (pl) |
| DK (1) | DK1753512T3 (pl) |
| EA (1) | EA012280B1 (pl) |
| ES (1) | ES2309765T3 (pl) |
| HR (1) | HRP20080499T3 (pl) |
| IL (1) | IL178727A (pl) |
| MX (1) | MXPA06013383A (pl) |
| NO (1) | NO20065907L (pl) |
| NZ (1) | NZ550513A (pl) |
| PL (1) | PL1753512T3 (pl) |
| PT (1) | PT1753512E (pl) |
| RS (1) | RS50613B (pl) |
| SI (1) | SI1753512T1 (pl) |
| WO (1) | WO2005118071A2 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1753512T3 (pl) | 2004-05-28 | 2009-03-31 | 4Sc Ag | Tetrahydropirydotiofeny |
| CA2568718A1 (en) | 2004-06-04 | 2005-12-15 | Altana Pharma Ag | Tetrahydropyridothiophenes for use in the treatment of cancer |
| WO2005120642A2 (en) | 2004-06-11 | 2005-12-22 | Altana Pharma Ag | Tetrahydropyridothiophenes for treating hyperproliferative disorders |
| EP1851229A1 (en) | 2005-02-09 | 2007-11-07 | Nycomed GmbH | Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer |
| JP2008542242A (ja) | 2005-05-25 | 2008-11-27 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のテトラヒドロピリドチオフェン |
| JP2008542243A (ja) | 2005-05-25 | 2008-11-27 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のテトラヒドロピリドチオフェン |
| JP2010500395A (ja) * | 2006-08-16 | 2010-01-07 | ４エスツェー アクチェンゲゼルシャフト | 癌治療のためのテトラヒドロピリドチオフェン誘導体 |
| CA2660604A1 (en) * | 2006-08-16 | 2008-02-21 | 4Sc Ag | Tetrahydrobenzothiophene derivatives |
| EP2404608B1 (en) * | 2009-03-04 | 2015-04-01 | Otsuka Pharmaceutical Co., Ltd. | Cholestanol derivative for combined use |
| TWI492759B (zh) * | 2008-03-05 | 2015-07-21 | Otsuka Pharma Co Ltd | 膽甾烷醇衍生物之併用用途 |
| TW201005466A (en) * | 2008-07-24 | 2010-02-01 | Advanced Analog Technology Inc | Low dropout regulator |
| HRP20120822T1 (hr) * | 2008-10-24 | 2012-11-30 | Grünenthal GmbH | Supstituirani 4,5,6,7-tetrahidrotienopiridini kao kcnq2/3 modulatori za lijeäśenje boli, epilepsije i urinarne inkontinencije |
| CN104478850A (zh) * | 2014-12-08 | 2015-04-01 | 上海应用技术学院 | 一种2-氨基噻吩-3甲酰胺的衍生物的制备方法 |
| EP4169925B1 (en) | 2018-06-19 | 2025-11-19 | Novartis AG | Process to make n-substituted tetrahydrothienopyridine derivatives |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE272078C (pl) | ||||
| DE1225167B (de) | 1965-04-07 | 1966-09-22 | Huels Chemische Werke Ag | Verfahren zur Herstellung aliphatischer, aromatischer oder gemischt aliphatisch-aromatischer Sulfone |
| JPS5498337A (en) | 1978-01-06 | 1979-08-03 | Dai Ichi Seiyaku Co Ltd | Anticarcinogenic and/or antimetastatic agent |
| DD272078A1 (de) | 1986-04-15 | 1989-09-27 | Dresden Arzneimittel | Verfahren zur herstellung von 6-substituierten 2-acylamio-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridin-3-carbonsaeure-derivaten |
| DE4039734A1 (de) | 1990-12-13 | 1992-06-17 | Basf Ag | Substituierte 2-aminothiophene enthaltende herbizide mittel |
| GB9310700D0 (en) | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Novel composition |
| JP3074640B2 (ja) | 1995-12-22 | 2000-08-07 | インターナショナル・ビジネス・マシーンズ・コーポレ−ション | 液晶表示装置の駆動方法 |
| GB9614718D0 (en) * | 1996-07-12 | 1996-09-04 | Bayer Ag | 3-ureido-pyridofurans and -pyridothiophenes |
| WO1999046267A1 (en) | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| AU2713599A (en) * | 1998-03-12 | 1999-09-27 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| AU5154699A (en) | 1998-09-02 | 2000-03-27 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives |
| GB0114185D0 (en) | 2001-06-12 | 2001-08-01 | Protherics Molecular Design Lt | Compounds |
| EP1392283A4 (en) * | 2001-05-16 | 2004-10-20 | Cytovia Inc | SUBSTITUTED CUMARINE AND CHINOLINE AS CASPASE ACTIVATORS |
| WO2003084947A1 (en) | 2002-04-09 | 2003-10-16 | Axxima Pharmaceuticals Ag | 4,5,6,7-tretrahydrobenzo[b] thiophene derivatives and methods for medical intervention against mycrobacterial infections |
| US20040171603A1 (en) | 2001-05-18 | 2004-09-02 | Janos Pato | Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor |
| US20030232994A1 (en) | 2001-10-04 | 2003-12-18 | Shao-Po Lu | Bicyclic thiophene derivatives and combinatorial libraries thereof |
| JP4448695B2 (ja) | 2002-03-27 | 2010-04-14 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規アルコキシピリジン−誘導体 |
| JP4103425B2 (ja) | 2002-03-28 | 2008-06-18 | セイコーエプソン株式会社 | 電気光学装置、電子機器及び投射型表示装置 |
| US7012100B1 (en) | 2002-06-04 | 2006-03-14 | Avolix Pharmaceuticals, Inc. | Cell migration inhibiting compositions and methods and compositions for treating cancer |
| CA2498399A1 (en) | 2002-09-12 | 2004-03-25 | Merck & Co., Inc. | Method of treating diabetes and related conditions |
| AU2003270390A1 (en) | 2002-09-12 | 2004-04-30 | Merck & Co., Inc. | Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use |
| TW200503994A (en) | 2003-01-24 | 2005-02-01 | Novartis Ag | Organic compounds |
| IL154306A0 (en) | 2003-02-05 | 2003-09-17 | Rimonyx Pharmaceuticals Ltd | Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof |
| US7138529B2 (en) | 2003-04-16 | 2006-11-21 | Hoffmann-La Roche Inc. | Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| US20070275962A1 (en) | 2003-09-10 | 2007-11-29 | Gpc Biotech Ag | Heterobicyclic Compounds as Pharmaceutically Active Agents |
| US7279488B2 (en) | 2003-10-01 | 2007-10-09 | Nycomed Gmbh | Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| US20050085531A1 (en) | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| GB0324653D0 (en) | 2003-10-22 | 2003-11-26 | Syngenta Participations Ag | Fungicides |
| CA2550091A1 (en) | 2003-12-19 | 2005-07-07 | Elixir Pharmaceuticals, Inc. | Methods of treating a disorder |
| US7745630B2 (en) | 2003-12-22 | 2010-06-29 | Justin Stephen Bryans | Triazolyl piperidine arginine vasopressin receptor modulators |
| PL1753512T3 (pl) | 2004-05-28 | 2009-03-31 | 4Sc Ag | Tetrahydropirydotiofeny |
| CA2568718A1 (en) | 2004-06-04 | 2005-12-15 | Altana Pharma Ag | Tetrahydropyridothiophenes for use in the treatment of cancer |
| WO2005120642A2 (en) | 2004-06-11 | 2005-12-22 | Altana Pharma Ag | Tetrahydropyridothiophenes for treating hyperproliferative disorders |
| SE0401970D0 (sv) | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Novel compounds |
| EP1851229A1 (en) | 2005-02-09 | 2007-11-07 | Nycomed GmbH | Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer |
| WO2006084904A1 (en) | 2005-02-11 | 2006-08-17 | Nycomed Gmbh | Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer |
| JP2008542242A (ja) | 2005-05-25 | 2008-11-27 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のテトラヒドロピリドチオフェン |
| JP2008542243A (ja) | 2005-05-25 | 2008-11-27 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のテトラヒドロピリドチオフェン |
| CA2660604A1 (en) | 2006-08-16 | 2008-02-21 | 4Sc Ag | Tetrahydrobenzothiophene derivatives |
-
2005
- 2005-05-25 PL PL05749649T patent/PL1753512T3/pl unknown
- 2005-05-25 MX MXPA06013383A patent/MXPA06013383A/es active IP Right Grant
- 2005-05-25 BR BRPI0511461-6A patent/BRPI0511461A/pt not_active IP Right Cessation
- 2005-05-25 DK DK05749649T patent/DK1753512T3/da active
- 2005-05-25 PT PT05749649T patent/PT1753512E/pt unknown
- 2005-05-25 KR KR1020067026452A patent/KR20070037578A/ko not_active Ceased
- 2005-05-25 EP EP05749649A patent/EP1753512B1/en not_active Expired - Lifetime
- 2005-05-25 NZ NZ550513A patent/NZ550513A/en unknown
- 2005-05-25 SI SI200530396T patent/SI1753512T1/sl unknown
- 2005-05-25 CA CA002567648A patent/CA2567648A1/en not_active Abandoned
- 2005-05-25 ES ES05749649T patent/ES2309765T3/es not_active Expired - Lifetime
- 2005-05-25 WO PCT/EP2005/052384 patent/WO2005118071A2/en not_active Ceased
- 2005-05-25 DE DE602005008050T patent/DE602005008050D1/de not_active Expired - Lifetime
- 2005-05-25 CN CN2005800246354A patent/CN1988934B/zh not_active Expired - Fee Related
- 2005-05-25 EA EA200602157A patent/EA012280B1/ru not_active IP Right Cessation
- 2005-05-25 US US11/597,142 patent/US7723523B2/en not_active Expired - Fee Related
- 2005-05-25 AU AU2005249718A patent/AU2005249718B2/en not_active Ceased
- 2005-05-25 HR HR20080499T patent/HRP20080499T3/xx unknown
- 2005-05-25 RS RSP-2008/0429A patent/RS50613B/sr unknown
- 2005-05-25 AT AT05749649T patent/ATE400319T1/de active
- 2005-05-25 JP JP2007513926A patent/JP4881297B2/ja not_active Expired - Fee Related
-
2006
- 2006-10-19 IL IL178727A patent/IL178727A/en not_active IP Right Cessation
- 2006-12-19 NO NO20065907A patent/NO20065907L/no not_active Application Discontinuation
-
2008
- 2008-10-07 CY CY20081101110T patent/CY1108399T1/el unknown
-
2009
- 2009-03-26 US US12/411,740 patent/US7803945B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108399T1 (el) | Τετραϋδροπυριδοθειοφαινια | |
| NL301145I2 (nl) | Tirbanibulin | |
| CY1122522T1 (el) | Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος | |
| UA96592C2 (uk) | Індолопіридини як модулятори кінезину eg5 | |
| WO2009074677A3 (en) | Pyrazolotriazines | |
| TW200643012A (en) | Pyrazolylcarboxanilides | |
| SG158133A1 (en) | Method for reversing multiple resistance in animal cells | |
| WO2008006883A3 (en) | Benzopyranopyrazoles | |
| SE0301650D0 (sv) | Novel compounds | |
| WO2005118592A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
| TW200744567A (en) | Phenylethylamine analogs and their use for treating glaucoma | |
| AU2005273867A1 (en) | Benzothienopyridines for use as inhibitors of Eg5 kinesin | |
| WO2006125815A3 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
| WO2006125813A3 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
| MX2008001638A (es) | Metodo de espaciado de piel entumecida. | |
| FR2858695B1 (fr) | Calculateur personnel. | |
| AU300902S (en) | Side table | |
| UA5977U (en) | 5-phenylpropenelydene-rodanin-3-propionate sodium possesses antihypoxic activity | |
| AU300903S (en) | Dining set | |
| AU305008S (en) | Shelving | |
| AU305697S (en) | Desk | |
| ES1056890Y (es) | Mesa de oficina. | |
| ES1051664Y (es) | Mesa desmontable. | |
| AU300892S (en) | Tables | |
| UY34598A (es) | Antranilamidas insecticidas |